83_FR_15461 83 FR 15392 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

83 FR 15392 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 69 (April 10, 2018)

Page Range15392-15393
FR Document2018-07266

Federal Register, Volume 83 Issue 69 (Tuesday, April 10, 2018) 
[Federal Register Volume 83, Number 69 (Tuesday, April 10, 2018)]
[Notices]
[Pages 15392-15393]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-07266]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Esophageal-Related P01s.
    Date: April 16, 2018.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Paul A. Rushing, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7345, 6707 Democracy Boulevard,

[[Page 15393]]

Bethesda, MD 20892-5452, (301) 594-8895, 
[email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; NIDDK Partnerships with 
Professional Societies Review Meeting.
    Date: April 17, 2018.
    Time: 2:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: John F. Connaughton, Ph.D., Chief, Scientific 
Review Branch, Review Branch, DEA, NIDDK, National Institutes of 
Health, Room 7007, 6707 Democracy Boulevard, Bethesda, MD 20892-
5452, (301) 594-7797, [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Loan Repayment Review 
Meeting.
    Date: April 18, 2018.
    Time: 2:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: John F. Connaughton, Ph.D., Chief, Scientific 
Review Branch, Review Branch, DEA, NIDDK, National Institutes of 
Health, Room 7007, 6707 Democracy Boulevard, Bethesda, MD 20892-
5452, (301) 594-7797 [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Digestive Diseases and 
Nutrition Clinical SBIRs.
    Date: April 19, 2018.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Paul A. Rushing, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7345, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 
594-8895 [email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Rearch; 93.849, Kidney Diseases, Urology and 
Hematology Research, National Institutes of Health, HHS)

David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-07266 Filed 4-9-18; 8:45 am]
 BILLING CODE 4140-01-P

15392 Federal Register / Vol. 83, No. 69 / Tuesday, April 10, 2018 / Notices Boulevard, Bethesda, MD 20892 (Telephone Time: 11:00 a.m. to 3:00 p.m. Place: The William F. Bolger Center, Bolger Conference Call). Agenda: To review and evaluate grant Center Hotel Lobby, Overland Room, 9600 Contact Person: Najma S. Begum, Ph.D., applications. Newbridge Drive, Potomac, MD 20854. Scientific Review Officer, Review Branch, Place: National Institutes of Health, 6707 Contact Person: David T. George, Ph.D., DEA, NIDDK, National Institutes of Health, Rockledge Drive, Bethesda, MD 20892 Acting Associate Director, Office of Research Room 7349, 6707 Democracy Boulevard, (Virtual Meeting). Administration, National Institute of Bethesda, MD 20892–5452, (301) 594–8894 Contact Person: John P. Holden, Ph.D., Biomedical Imaging and Bioengineering, begumn@niddk.nih.gov. Scientific Review Officer, 6707 Democracy 6707 Democracy Boulevard, Room 920, Name of Committee: National Institute of Boulevard, Room 920, Democracy Two, Bethesda, MD 20892. Diabetes and Digestive and Kidney Diseases Bethesda, MD 20892, (301) 496–8775, Any interested person may file written Special Emphasis Panel; NIDDK Multi-Center john.holden@mail.nih.gov. comments with the committee by forwarding Clinical Trial (U01) Review. the statement to the Contact Person listed on Dated: April 4, 2018. Date: May 10, 2018. this notice. The statement should include the Time: 11:00 a.m. to 12:30 p.m. David D. Clary, name, address, telephone number and when Agenda: To review and evaluate grant Program Analyst, Office of Federal Advisory applicable, the business or professional applications Committee Policy. affiliation of the interested person. Place: National Institutes of Health, Two [FR Doc. 2018–07264 Filed 4–9–18; 8:45 am] Information is also available on the Democracy Plaza, 6707 Democracy BILLING CODE 4140–01–P Institute’s/Center’s home page: http:// Boulevard, Bethesda, MD 20892 (Telephone www.nibib1.nih.gov/about/NACBIB/ Conference Call). NACBIB.htm, where an agenda and any Contact Person: Jian Yang, Ph.D., Scientific additional information for the meeting will Review Officer, Review Branch, DEA, DEPARTMENT OF HEALTH AND be posted when available. NIDDK, National Institutes of Health, Room HUMAN SERVICES 7111, 6707, Democracy Boulevard, Bethesda, Dated: April 4, 2018. MD 20892–5452, (301) 594–7799, yangj@ National Institutes of Health David D. Clary, extra.niddk.nih.gov. Program Analyst, Office of Federal Advisory National Institute of Biomedical Committee Policy. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Imaging and Bioengineering; Notice of [FR Doc. 2018–07265 Filed 4–9–18; 8:45 am] Endocrinology and Metabolic Research; Meeting BILLING CODE 4140–01–P 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology Pursuant to section 10(d) of the and Hematology Research, National Institutes Federal Advisory Committee Act, as amended, notice is hereby given of a DEPARTMENT OF HEALTH AND of Health, HHS) following meeting. HUMAN SERVICES Dated: April 4, 2018. David D. Clary, The meeting will be open to the National Institutes of Health Program Analyst, Office of Federal Advisory public as indicated below, with Committee Policy. attendance limited to space available. National Institute of Diabetes and [FR Doc. 2018–07267 Filed 4–9–18; 8:45 am] Individuals who plan to attend and Digestive and Kidney Diseases; Notice need special assistance, such as sign of Closed Meetings BILLING CODE 4140–01–P language interpretation or other Pursuant to section 10(d) of the reasonable accommodations, should Federal Advisory Committee Act, as DEPARTMENT OF HEALTH AND notify the Contact Person listed below amended, notice is hereby given of the HUMAN SERVICES in advance of the meeting. following meetings. The meeting will be closed to the The meetings will be closed to the National Institutes of Health public in accordance with the public in accordance with the provisions set forth in sections provisions set forth in sections National Institute of Biomedical 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Imaging and Bioengineering; Notice of as amended. The grant applications as amended. The grant applications and Closed Meeting and/or contract proposals and the the discussions could disclose Pursuant to section 10(d) of the discussions could disclose confidential confidential trade secrets or commercial Federal Advisory Committee Act, as trade secrets or commercial property property such as patentable material, amended, notice is hereby given of the such as patentable material, and and personal information concerning following meeting. personal information concerning individuals associated with the grant The meeting will be closed to the individuals associated with the grant applications, the disclosure of which public in accordance with the applications and/or contract proposals, would constitute a clearly unwarranted provisions set forth in sections the disclosure of which would invasion of personal privacy. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., constitute a clearly unwarranted Name of Committee: National Institute of as amended. The grant applications and invasion of personal privacy. Diabetes and Digestive and Kidney Diseases the discussions could disclose Name of Committee: National Advisory Special Emphasis Panel; Esophageal-Related confidential trade secrets or commercial Council for Biomedical Imaging and P01s. property such as patentable material, Bioengineering. Date: April 16, 2018. and personal information concerning Date: May 23, 2018. Time: 1:00 p.m. to 5:00 p.m. individuals associated with the grant Open: 8:30 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications, the disclosure of which Agenda: Report from the Acting Institute applications. daltland on DSKBBV9HB2PROD with NOTICES would constitute a clearly unwarranted Director, other Institute Staff and Scientific Place: National Institutes of Health, Two Presentation. Democracy Plaza, 6707 Democracy invasion of personal privacy. Place: The William F. Bolger Center, Bolger Boulevard, Bethesda, MD 20892 (Telephone Name of Committee: National Institute of Center Hotel Lobby, Overland Room, 9600 Conference Call). Biomedical Imaging and Bioengineering Newbridge Drive, Potomac, MD 20854. Contact Person: Paul A. Rushing, Ph.D., Special Emphasis Panel; Loan Repayment Closed: 1:00 p.m. to 3:00 p.m. Scientific Review Officer, Review Branch, Program (LRP) review, (2018/08). Agenda: To review and evaluate grant DEA, NIDDK, National Institutes of Health, Date: April 23, 2018. applications and/or proposals. Room 7345, 6707 Democracy Boulevard, VerDate Sep<11>2014 16:56 Apr 09, 2018 Jkt 244001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\10APN1.SGM 10APN1

Federal Register / Vol. 83, No. 69 / Tuesday, April 10, 2018 / Notices 15393 Bethesda, MD 20892–5452, (301) 594–8895, (Catalogue of Federal Domestic Assistance 276–2252, Email: tracy.goss@ rushingp@extra.niddk.nih.gov. Program Nos. 93.847, Diabetes, samhsa.hhs.gov. This notice is being published less than 15 Endocrinology and Metabolic Research; days prior to the meeting due to the timing 93.848, Digestive Diseases and Nutrition Carlos Castillo, limitations imposed by the review and Rearch; 93.849, Kidney Diseases, Urology Committee Management Officer, SAMHSA. funding cycle. and Hematology Research, National Institutes [FR Doc. 2018–07250 Filed 4–9–18; 8:45 am] of Health, HHS) Name of Committee: National Institute of BILLING CODE 4162–20–P Diabetes and Digestive and Kidney Diseases David D. Clary, Special Emphasis Panel; NIDDK Partnerships Program Analyst, Office of Federal Advisory with Professional Societies Review Meeting. Committee Policy. Date: April 17, 2018. DEPARTMENT OF HOMELAND Time: 2:00 p.m. to 6:00 p.m. [FR Doc. 2018–07266 Filed 4–9–18; 8:45 am] SECURITY Agenda: To review and evaluate grant BILLING CODE 4140–01–P applications. U.S. Citizenship and Immigration Place: National Institutes of Health, Two Services Democracy Plaza, 6707 Democracy DEPARTMENT OF HEALTH AND [OMB Control Number 1615–0100] Boulevard, Bethesda, MD 20892 (Telephone HUMAN SERVICES Conference Call). Agency Information Collection Contact Person: John F. Connaughton, Substance Abuse and Mental Health Activities; Revision of a Currently Ph.D., Chief, Scientific Review Branch, Services Administration Approved Collection: Request for the Review Branch, DEA, NIDDK, National Institutes of Health, Room 7007, 6707 Center for Substance Abuse Return of Original Documents Democracy Boulevard, Bethesda, MD 20892– Treatment; Notice of Meeting AGENCY: U.S. Citizenship and 5452, (301) 594–7797, connaughtonj@ extra.niddk.nih.gov. Immigration Services, Department of Pursuant to Public Law 92–463, Homeland Security. This notice is being published less than 15 notice is hereby given that the days prior to the meeting due to the timing ACTION: 60-day notice. Substance Abuse and Mental Health limitations imposed by the review and Services Administration’s (SAMHSA) funding cycle. SUMMARY: The Department of Homeland Center for Substance Abuse Treatment Security (DHS), U.S. Citizenship and Name of Committee: National Institute of (CSAT) National Advisory Council will Diabetes and Digestive and Kidney Diseases Immigration (USCIS) invites the general meet on April 23, 2018, 2:00 p.m.–3:00 public and other Federal agencies to Special Emphasis Panel; Loan Repayment Review Meeting. p.m. (EDT) in a closed teleconference comment upon this proposed revision of Date: April 18, 2018. meeting. a currently approved collection of Time: 2:00 p.m. to 5:00 p.m. The meeting will include discussions information. In accordance with the Agenda: To review and evaluate grant and evaluations of grant applications Paperwork Reduction Act (PRA) of applications. reviewed by SAMHSA’s Initial Review 1995, the information collection notice Place: National Institutes of Health, Two Groups, and involve an examination of is published in the Federal Register to Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone confidential financial and business obtain comments regarding the nature of Conference Call). information as well as personal the information collection, the Contact Person: John F. Connaughton, information concerning the applicants. categories of respondents, the estimated Ph.D., Chief, Scientific Review Branch, Therefore, the meeting will be closed to burden (i.e., the time, effort, and Review Branch, DEA, NIDDK, National the public as determined by the resources used by the respondents to Institutes of Health, Room 7007, 6707 SAMHSA Assistant Secretary for Mental respond), the estimated cost to the Democracy Boulevard, Bethesda, MD 20892– Health and Substance Use in accordance respondent, and the actual information 5452, (301) 594–7797 connaughtonj@ with Title 5 U.S.C 552b(c)(4) and (6) and collection instruments. extra.niddk.nih.gov. Title 5 U.S.C. App. 2, § 10(d). DATES: Comments are encouraged and This notice is being published less than 15 days prior to the meeting due to the timing Meeting information and a roster of will be accepted for 60 days until June limitations imposed by the review and Council members may be obtained by 11, 2018. funding cycle. accessing the SAMHSA Committee ADDRESSES: All submissions received Name of Committee: National Institute of website at http://www.samhsa.gov/ must include the OMB Control Number Diabetes and Digestive and Kidney Diseases about-us/advisory-councils/csat- 1615–0100 in the body of the letter, the Special Emphasis Panel; Digestive Diseases national-advisory-council or by agency name and Docket ID USCIS– and Nutrition Clinical SBIRs. contacting the CSAT National Advisory 2008–0010. To avoid duplicate Date: April 19, 2018. Council Designated Federal Officer; submissions, please use only one of the Time: 1:00 p.m. to 3:00 p.m. Tracy Goss (see contact information following methods to submit comments: Agenda: To review and evaluate grant applications. below). (1) Online. Submit comments via the Place: National Institutes of Health, Two Council Name: SAMHSA’s Center for Federal eRulemaking Portal website at Democracy Plaza, 6707 Democracy Substance Abuse Treatment National http://www.regulations.gov under e- Boulevard, Bethesda, MD 20892 (Telephone Advisory Council. Docket ID number USCIS–2008–0010; Conference Call). (2) Mail. Submit written comments to Contact Person: Paul A. Rushing, Ph.D., Date/Time/Type: April 23, 2018, 2:00 DHS, USCIS, Office of Policy and Scientific Review Officer, Review Branch, p.m.–3:00 p.m. EDT, CLOSED. Strategy, Chief, Regulatory Coordination daltland on DSKBBV9HB2PROD with NOTICES DEA, NIDDK, National Institutes of Health, Place: SAMHSA, 5600 Fishers Lane, Division, 20 Massachusetts Avenue NW, Room 7345, 6707 Democracy Boulevard, Rockville, Maryland 20857. Washington, DC 20529–2140. Bethesda, MD 20892–5452, (301) 594–8895 rushingp@extra.niddk.nih.gov. Contact: Tracy Goss, Designated FOR FURTHER INFORMATION CONTACT: This notice is being published less than 15 Federal Officer, CSAT National USCIS, Office of Policy and Strategy, days prior to the meeting due to the timing Advisory Council, 5600 Fishers Lane, Regulatory Coordination Division, limitations imposed by the review and Rockville, Maryland 20857 (mail), Samantha Deshommes, Chief, 20 funding cycle. Telephone: (240) 276–0759, Fax: (240) Massachusetts Avenue NW, VerDate Sep<11>2014 16:56 Apr 09, 2018 Jkt 244001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\10APN1.SGM 10APN1


Document Created: 2018-04-09 23:51:44
Document Modified: 2018-04-09 23:51:44
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesApril 16, 2018.
FR Citation83 FR 15392 
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR